Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

NAFLD in the 20’s. From Epidemiology to Management (PART - II)

Author(s): Amedeo Lonardo and Giovanni Targher

Volume 26, Issue 32, 2020

Page: [3908 - 3908] Pages: 1

DOI: 10.2174/138161282632200811172901

[1]
Tovoli F, Ferri S, Piscaglia F. Hepatocellular carcinoma in non alcoholic fatty liver disease. Curr Pharm Des 2020; 26(32): 3909-14.
[2]
Ballestri S, Tana C, Di Girolamo M, et al. Semi-quantitative ultrasonographic evaluation of NAFLD. Curr Pharm Des 2020; 26(32): 3915-27.
[3]
Pennisi G, Celsa C, Giammanco A, Spatola F, Petta S. The relevance of noninvasive tools to assess fibrosis in non-alcoholic fatty liver disease. Curr Pharm Des 2020; 26(32): 3928-38.

© 2024 Bentham Science Publishers | Privacy Policy